Literature DB >> 24667721

Agreement between HADS classifications and single-item screening questions for anxiety and depression: a cross-sectional survey of cancer patients.

L J Mackenzie1, M L Carey2, R W Sanson-Fisher2, C A D'Este2, C L Paul2, S L Yoong3.   

Abstract

BACKGROUND: We assessed agreement between reported anxiety and depression levels of cancer patients using (i) single self-report items and (ii) the Hospital Anxiety and Depression Scale (HADS). We also explored whether anxiety and depression assessment by (i) single self-report items or (ii) the HADS was most strongly associated with a preference to be offered professional assistance. The proportion of patients indicating that they would accept (or were currently using) professional support if they were experiencing anxiety or depression was also examined. PATIENTS AND METHODS: A consecutive sample of cancer patients undergoing radiotherapy at four metropolitan public hospitals in Australia completed a touch screen computer survey. A consecutive subsample of patients attending three of these treatment centres answered additional questions about psychological support preferences.
RESULTS: Of 304 respondents, 54% [95% confidence interval (CI) 48% to 60%] perceived that they were currently experiencing mild to severe anxiety and depression. 22% (95% CI 18% to 27%) indicated a preference to be offered professional help. There was moderate agreement between the HADS and single-item responses for categorisation of anxiety and depression. Patient-perceived mild to severe anxiety and depression levels appeared to be the best measure for identifying those with a preference to be offered professional assistance. Of a subsample of 193 respondents, 89% (95% CI 84% to 93%) indicated that if they were experiencing anxiety or depression, they would accept (or were currently using) professional support.
CONCLUSIONS: Single-item screening in a cancer care setting may not adequately capture clinical anxiety and depression. However, single-items assessing patients' perceived levels of anxiety and depression are useful indicators of whether patients want to be offered, and are likely to accept, psychosocial care.

Entities:  

Keywords:  HADS; anxiety; depression; oncology; questionnaire; single-item question

Mesh:

Year:  2014        PMID: 24667721     DOI: 10.1093/annonc/mdu023

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  9 in total

1.  Mental Health in Postoperative Thyroid Patients During the COVID-19 Pandemic.

Authors:  Shijie Yang; Xiequn Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  Treatment Adherence to Nucleos(t)ide Analogs in Chinese Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma: A Single-Center Cross-Sectional Study.

Authors:  Yueyue Li; Anni Chen; Hui Wang; Lu Han; Rong Wang; Guoqing Zhang; Yongfang Yuan
Journal:  Patient Prefer Adherence       Date:  2021-08-10       Impact factor: 2.711

3.  Agreement for depression diagnosis between DSM-IV-TR criteria, three validated scales, oncologist assessment, and psychiatric clinical interview in elderly patients with advanced ovarian cancer.

Authors:  Wadih Rhondali; Gilles Freyer; Virginie Adam; Marilène Filbet; Martine Derzelle; Gaelle Abgrall-Barbry; Sophie Bourcelot; Jean-Louis Machavoine; Muriel Chomat-Neyraud; Olivier Gisserot; Rémi Largillier; Annick Le Rol; Frank Priou; Pierre Saltel; Claire Falandry
Journal:  Clin Interv Aging       Date:  2015-07-13       Impact factor: 4.458

4.  How well do cancer survivor self-classifications of anxiety, depression and stress agree with a standardised tool? Results of a cross-sectional study.

Authors:  Mariko Carey; Jamie Bryant; Alison Zucca; Alix Hall; Alice Grady; Sophie Dilworth; Kerry Peek
Journal:  PLoS One       Date:  2019-09-20       Impact factor: 3.240

5.  Screening and Psycho-Oncological Support for Patients With Head and Neck Cancer and Brain Malignancies Before Radiotherapy With Mask Fixation: Results of a Feasibility Study.

Authors:  Sebastian Adeberg; Christina Sauer; Lena Lambert; Sebastian Regnery; Paul Windisch; Karim Zaoui; Christian Freudlsperger; Julius Moratin; Benjamin Farnia; Christoph Nikendei; Juergen Krauss; Johannes C Ehrenthal; Rami El Shafie; Juliane Hörner-Rieber; Laila König; Sati Akbaba; Kristin Lang; Thomas Held; Stefan Rieken; Juergen Debus; Hans-Christoph Friederich; Imad Maatouk
Journal:  Front Psychol       Date:  2021-12-16

6.  Evaluating How Mental Health Changed in Australia through the COVID-19 Pandemic: Findings from the 'Taking the Pulse of the Nation' (TTPN) Survey.

Authors:  Ferdi Botha; Peter Butterworth; Roger Wilkins
Journal:  Int J Environ Res Public Health       Date:  2022-01-04       Impact factor: 3.390

7.  Optical Coherence Tomography Angiography Biomarkers of Retinal Thickness and Microvascular Alterations in Sjogren's Syndrome.

Authors:  Ren Liu; Yan Wang; Qiuyu Li; Qiang Xia; Tian Xu; Ting Han; Shuang Cai; Shuilin Luo; Rui Wu; Yi Shao
Journal:  Front Neurol       Date:  2022-03-08       Impact factor: 4.003

8.  Expressive Arts Therapy Combined with Progressive Muscle Relaxation following Music for Perioperative Patients with Gynecological Malignancies: A Pilot Study.

Authors:  Xing Liu; Jian-Hua Ren; Sha-Sha Jiang; Yan Tan; Se-Ge Ma; Yan Huang
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

9.  COVID-19 Scientific Facts vs. Conspiracy Theories: Is Science Failing to Pass Its Message?

Authors:  Marios Constantinou; Antonios Kagialis; Maria Karekla
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.